Shanghai, China

Sen Yuan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Boehringer Ingelheim Vetmedica (China) Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sen Yuan. Retrieved from https://idiyas.com/inventor/sen-yuan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Sen Yuan in Recombinant Virus Technology.

Introduction

Sen Yuan is an accomplished inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant viruses. His work focuses on creating innovative solutions that can enhance vaccine production and immunogenic compositions.

Latest Patents

Sen Yuan holds a patent for a recombinant virus capable of stably expressing target proteins. This invention provides a method to generate a recombinant virus that can effectively produce target proteins. The recombinant virus developed through this method is particularly useful for producing immunogenic compositions or vaccines, which can have a profound impact on public health.

Career Highlights

Sen Yuan is currently employed at Boehringer Ingelheim Vetmedica (China) Co., Ltd. His role at the company allows him to apply his expertise in biotechnology and contribute to advancements in veterinary medicine. His innovative approach and dedication to research have positioned him as a valuable asset in his field.

Collaborations

Sen Yuan collaborates with Guanggang Ma, a fellow researcher. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in biotechnology.

Conclusion

Sen Yuan's work in recombinant virus technology showcases his commitment to advancing medical science. His patent and contributions to Boehringer Ingelheim Vetmedica (China) Co., Ltd. highlight the potential of biotechnology in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…